跳转到主要内容
insight

Press Release

Share

KBR Signs Acetic Acid Technology Alliance with Chiyoda

Publish date

Houston, Texas - November 3, 2014 - KBR Inc. (NYSE: KBR) announced today it has signed an agreement with Chiyoda Corporation, a leading engineering and construction firm in Japan, to license its CT-ACETICA technology.

Chiyoda developed the CT-ACETICA process, a methanol-carbonylation process that uses methanol and carbon monoxide as feedstock to produce acetic acid. The process employs a heterogeneous catalyst for the efficient production of acetic acid.
The process has tangible advantages including i) the easy-to-handle catalyst, ii) limited loss of precious rhodium, iii) efficient reactor, iv) low content of by-products, and v) relatively low corrosivity. Acetic acid is used in the production of paints and coatings, plastic bottles, adhesives and disinfectants.

Under the terms of the agreement, KBR will exclusively license CT-ACETICA technology worldwide. CT-ACETICA is uniquely positioned as an open-market licensed acetic acid technology.

KBR's vast global marketing channels will provide Chiyoda increased opportunities to license their technology," said Stuart Bradie, KBR President and CEO. "This technology adds to our already extensive chemicals technology portfolio."

Expected revenue from this alliance will be booked as licenses are awarded to the Hydrocarbons business segment.

About KBR

KBR is a global engineering, construction and services company supporting the energy, hydrocarbons, chemicals, industrial, civil infrastructure, minerals, government services and commercial markets. For more information, visit www.kbr.com.

Forward Looking Statement

The statements in this press release that are not historical statements are forward-looking statements within the meaning of the federal securities laws. These statements are subject to numerous risks and uncertainties, many of which are beyond the company's control that could cause actual results to differ materially from the results expressed or implied by the statements. These risks and uncertainties include, but are not limited to: the outcome of and the publicity surrounding audits and investigations by domestic and foreign government agencies and legislative bodies; potential adverse proceedings by such agencies and potential adverse results and consequences from such proceedings; the scope and enforceability of the company's indemnities from its former parent; changes in capital spending by the company's customers; the company's ability to obtain contracts from existing and new customers and perform under those contracts; structural changes in the industries in which the company operates, escalating costs associated with and the performance of fixed-fee projects and the company's ability to control its cost under its contracts; claims negotiations and contract disputes with the company's customers; changes in the demand for or price of oil and/or natural gas; protection of intellectual property rights; compliance with environmental laws; changes in government regulations and regulatory requirements; compliance with laws related to income taxes; unsettled political conditions, war and the effects of terrorism; foreign operations and foreign exchange rates and controls; the development and installation of financial systems; increased competition for employees; the ability to successfully complete and integrate acquisitions; and operations of joint ventures, including joint ventures that are not controlled by the company.

KBR's most recently filed Annual Report on Form 10-K/A, any subsequent Form 10-Qs and 8-Ks, and other Securities and Exchange Commission filings discuss some of the important risk factors that KBR has identified that may affect the business, results of operations and financial condition. Except as required by law, KBR undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

CONTACT:
Zac Nagle
Vice President, Investor Relations
713-753-5082
[email protected]

or

Rick Goins
Director, Communications
713-753-3800
[email protected]

Cookie 政策